OXBDF - Oxford BioMedica plc (OXBDF) CEO John Dawson on Q2 2019 Results - Earnings Call Transcript
Oxford BioMedica plc (OXBDF)
Q2 2019 Earnings Conference Call
September 4, 2019 8:00 A.M. ET
Company Participants
Catherine Isted - Head-Corporate Development and Investor Relations
John Dawson - Chief Executive Officer
Stuart Paynter - Chief Financial Officer
Kyriacos Mitrophanous - Chief Scientific Officer
Conference Call Participants
Stefan Hamill - Numis Securities
Charles Weston - RBC
Brian White - Cantor Fitzgerald
Joe Pantginis - H.C. Wainwright
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Oxford BioMedica Interim Results for the Six Months Ended June 2019. At this time, all participants